Instrument Inactif

Communiqués Idenix Pharmaceuticals Inc

Actions

US45166R2040

Produits pharmaceutiques

Cours en clôture Nasdaq
- ^USD	-

29/07/14	Idenix Pharmaceuticals : Merck dépasse les attentes malgré la concurrence des génériques	RE
29/07/14	Merck : dépasse les attentes au T2 malgré les génériques	RE

Communiqués

10/06/14	Idenix Pharmaceuticals : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Idenix Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Merck	BU
10/06/14	Idenix Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Idenix Pharmaceuticals Inc.	PR
09/06/14	Idenix Pharmaceuticals : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Idenix Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Merck	BU
23/05/14	Idenix Pharmaceuticals : Clinical Test Results, Improved Medical Care, and Rejection of Buyout Proposal by Medical Companies - Analyst Notes on AstraZeneca, LifePoint, Insmed, Dendreon and Idenix Pharmaceuticals	PR
24/03/14	Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case	GL
14/03/14	Idenix Pharmaceuticals Inc : Files Patent Infringement Lawsuits Against Gilead Sciences in Europe	GL
14/03/14	Idenix Pharmaceuticals Inc : INTENTE UN PROCES CONTRE GILEAD SCIENCES EN EUROPE POUR VIOLATION DE BREVET	GL
29/01/14	Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Patent Interference	GL
28/01/14	Idenix to Raise $106.7 Million Through Registered Direct Offering	GL
20/12/13	Idenix Pharmaceuticals Inc : Price Movements, Leadership Appointments, Patient Enrollments and Supply Agreements - Research Report on Santarus, Hologic, Brookdale, Idenix, and Biodel	PR
09/12/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Announces Declaration of Senior Party in a Second Patent Interference by the USPTO	PU
25/11/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals to Present at Two Upcoming Healthcare Conferences	PU
30/10/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2013 Financial Results and Provides HCV Pipeline Update	PU
28/10/13	Idenix Pharmaceuticals Inc : Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2013 Financial Results and HCV Pipeline Update on Wednesday, October 30, 2013	PU
01/10/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Announces Nucleotide Prodrug Program Poster Presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting	PU
07/08/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Reports Second Quarter and Six Month 2013 Financial Results	PU
06/08/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals, Inc. to Hold Second Quarter and Six Month 2013 Financial Results Conference Call on Wednesday, August 7, 2013	PU
20/06/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Announces Update on Development Program for Its Lead HCV Nucleotide Prodrug Candidate, IDX20963	PU
11/06/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals to Present at the Wells Fargo Securities 2013 Healthcare Conference	PU
10/06/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors	PU
30/05/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Announces Initiation of Phase II All-Oral Combination Study of Samatasvir (IDX719) and Simeprevir (TMC435) for the Treatment of Hepatitis C Virus (HCV) Infection	PU
08/05/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals to Present at Three Upcoming Healthcare Conferences	PU
30/04/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Reports First Quarter 2013 Financial Results	PU
08/04/13	Idenix Pharmaceuticals Inc : Idenix Announces Data Presentation at the 48th Annual Meeting of the European Association for the Study of the Liver (EASL)	PU
22/03/13	Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Phase of the Interference	PU